Tirzepatide can cause acute kidney injury, particularly with severe gastrointestinal symptoms causing dehydration
Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy
GLP-1 receptor agonists also increase intestinal fluid secretion through chloride channel activation, as described in preclinical and clinical motility studies
As long as you use hydroquinone, your body will produce lesser melanin, and you will become lighter over time
A landmark review published in Clinical Obesity (Urbina et al., 2025) has provided the "what": GLP-1 users are suffering from severe deficiencies in Vitamin D, Iron, B12, and protein
Receptor Interaction Studies: The combination allows detailed investigation of ghrelin receptor and GHRH receptor signaling behavior